Activation of BDNF and TrkB is produced after administration of conventional antidepressant drugs, such as fluoxetine and citalopram [28, 101, 121], which is associated with the reduction of most of the symptoms of depression [97, 122–124]. This evidence concerns the gene NTRK2 and depressive symptom measurement.